Table 7 Characteristics of patients with recommendation change from HT to CTÂ +Â HT
Variable | Value (NÂ =Â 8) |
|---|---|
Recurrence score, median (range) | 30 (18–51) |
Risk group, n (%) | |
 Low risk | 5 (63%) |
 Non-low risk | 3 (38%) |
 Age, median (range) | 61 (44–73) |
Menopausal status, n (%) | |
 Premenopausal | 1 (13%) |
 Postmenopausal | 7 (88%) |
pT stage, n (%) | |
 T1b | 1 (13%) |
 T1c | 6 (75%) |
 T2 | 1 (13%) |
pN stage, n (%) | |
 pN0 | 5 (63%) |
 pN1a | 3 (38%) |
Histologic type, n (%) | |
 Invasive ductal carcinoma | 8 (100%) |
Tumor grade (BRE), n (%) | |
 G 2 | 6 (75%) |
 G 3 | 2 (25%) |
Peritumoral lympho-vascular invasion, n (%) | |
 No | 5 (53%) |
 Yes | 3 (38%) |